Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06224426

Oxygen Concentration Target in Stroke Endovascular Treatment

The goal of this clinical trial is to compare the effects of different concentrations of normobaric oxygen on early neurological improvement in acute ischemic stroke (AIS) patients receiving endovascular therapy (EVT). The main questions it aims to answer are:

* Evaluating the impact of normobaric high-concentration oxygen versus low-concentration oxygen on early neurological function after EVT. * Evaluating the safety of high and low normobaric oxygen concentration in patients with ischemic stroke.

Participants will (1) receive EVT under general anesthesia; (2) be randomly assigned 1:1 to receive oxygen therapy with FiO2=80% or FiO2=30% through endotracheal intubation during the operation, and the gas flow rate was set at 4L /min.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Beijing Tiantan Hospital, Capital Medical University

Beijing, Beijing Municipality, 100070, China

Location status: Recruiting

Location contact

Ruquan Han, Ph.D

CONTACT

[email protected]

86-13701285393

About this study

The optimal fraction of inspired oxygen (FiO2) during EVT under general anesthesia is currently uncertain. This is a randomized controlled trial (RCT) designed to assess the impact of normobaric high-concentration oxygen versus low-concentration oxygen on early neurological function following EVT. It is a prospective, open-label, parallel-design RCT planned to be conducted at Beijing Tiantan Hospital, Capital Medical University. It is anticipated that 200 cases of AIS patients undergoing EVT under general anesthesia will be consecutively enrolled from 2024 to 2026. Eligible participants will be randomly assigned in a 1:1 ratio. After general anesthesia induction, patients will receive continuous inhalation of oxygen with either FiO2=80% or FiO2=30% through endotracheal intubation until the end of the procedure, with a gas flow rate set at 4 L/min. The positive end-expiratory pressure (PEEP) is uniformly set to 5 cmH2O to balance its effect on pulmonary oxygen delivery. The primary outcome will be the occurrence of early neurological improvement (NIHSS score of 10 points 24±2 hours after EVT). Safety outcomes include potential adverse events such as site infection, three-month mortality, etc.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥18 years.
  • Anterior circulation occlusive stroke is confirmed by CT angiography (CTA), magnetic resonance angiography (MRA) or digital subtraction angiography (DSA), and occlusions of intracranial internal carotid artery (ICA) or M1 segment of the middle cerebral artery (MCA) were involved.
  • NIHSS score at admission: 6-20.
  • Randomization can be completed within 24 hours after stroke onset.

Exclusion criteria

  • Stroke onset within 6-24 hours with a CT perfusion imaging (CTP)-assessed mismatched area<15 ml.
  • Presence of anemia, defined as hemoglobin levels o below 120 g/L in men and below 110 g/L in women.
  • Pre-stroke modified Rankin scale (mRS) score ≥2.
  • Complicated by severe agitation and seizures.
  • Evidence of intracranial hemorrhage at admission.
  • Presence of chronic obstructive pulmonary disease, asthma, or other respiratory conditions, or requirement for daily supplemental oxygen or mechanical ventilation.
  • Baseline arterial blood gas analysis indicating impaired gas exchange: PaO2 < 60 mmHg on room air, or oxygenation index (PaO2/FiO2) < 300 mmHg with supplemental oxygen.
  • Emergency chest CT reveals significant pulmonary parenchymal infection.
  • An oxygen mask or ventilator must be used before anesthesia to maintain a SpO2≥94%.
  • Loss of airway protective reflex or vomiting aspiration upon admission.

Treatment and study plan

Normobaric high-concentration oxygen

Other

During endovascular therapy, eligible participants will receive FiO2=80% through endotracheal intubation, with a gas flow rate set at 4 L/min.

Normobaric low-concentration oxygen

Other

During endovascular therapy, eligible participants will receive FiO2=30% through endotracheal intubation, with a gas flow rate set at 4 L/min.

Primary outcomes

  1. the incidence of early neurological improvement (ENI)

    Time frame: 24±2 hours after EVT

    ENI is defined as an NIHSS score of <10 points at 24±2 hours after EVT

Secondary outcomes

  1. ΔNIHSS at 24±2 hours after EVT

    Time frame: 24±2 hours after EVT

    baseline NIHSS score - NIHSS score at 24±2 h

  2. the final infarct volume

    Time frame: 72 hours post-randomization

    After collecting cranial CT images, the infarct volume was delineated using ITK-SNAP software.

  3. early neurological deterioration (END)

    Time frame: 1 day after reperfusion therapy

    an increase of ≥4 from the baseline NIHSS score on day 1 after reperfusion therapy in AIS patients

  4. Postoperative pulmonary complications

    Time frame: within 7 days after endovascular therapy

    defined as a composite measure encompassing pulmonary infections, atelectasis, pleural effusion, respiratory failure, bronchospasm, and pneumothorax

  5. overall mRS distribution at 90 days

    Time frame: 90 days after stroke onset

    modified Rankin scale (mRS) scores are distributed between 0 and 6

  6. favorable functional outcome

    Time frame: 90 days after stroke onset

    an mRS score of 0-2 at 90 days

Other outcomes

  1. Postoperative baseline PaO2

    Time frame: From the end of the intervention procedure until the time just before the tracheal tube is removed.

    Arterial partial oxygen pressure based on arterial blood gas

  2. Postoperative baseline oxygenation index

    Time frame: From the end of the intervention procedure until the time just before the tracheal tube is removed.

    oxygenation index=PaCO2/FiO2

  3. symptomatic ICH

    Time frame: 24±12 hours after EVT

    defined as the presence of hemorrhage on CT at 24±12 h accompanied by an NIHSS score increase≥4

  4. all-cause mortality at 90 days

    Time frame: 90 days after stroke onset

    deaths from any cause during the 3-month follow-up period

  5. stroke-related death

    Time frame: within 7 days after endovascular therapy

    typically defined as death directly attributable to the stroke and its complications, encompassing but not limited to severe cerebral edema, brain herniation, infections, cardiac diseases, pulmonary embolism, and deep vein thrombosis occurring during the acute phase of AIS

Study contacts

Contact information is provided by the study sponsor or research team.

Ruquan Han, Ph.D

CONTACT

[email protected]

+86 13701285393

Zhengfang Hu, M.D

CONTACT

[email protected]

+86 13041084927

Sponsors and collaborators

Lead sponsor

Beijing Tiantan Hospital

Other

Registry information

Official study title

Oxygenation Targets for Endovascular Therapy in Acute Ischemic Stroke Patients (Oxy-TARGET)

Acronym: Oxy-TARGET

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Jan 25, 2024
Registry last updated
Dec 2, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.